Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 91.45% is in line with its 5-year average of 96.73%, near the high end of its 5-year range (0.05%–113.20%).
As of the fiscal period ended Tuesday, June 30, 2026. 3.42% below its 12-month average of 94.69%.
Reported quarterly debt to assets ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 91.45%.
DEBT TO ASSETS RATIO
91.45%
DEBT TO ASSETS RATIO AVG TTM
94.69%
DEBT TO ASSETS RATIO AVG 3Y
99.88%
DEBT TO ASSETS RATIO AVG 5Y
96.73%
DEBT TO ASSETS RATIO AVG 10Y
N/A
DEBT TO ASSETS RATIO AVG 15Y
N/A
DEBT TO ASSETS RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-3.42%
CURRENT VS 3Y AVG
-8.44%
CURRENT VS 5Y AVG
-5.46%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.11%
median of 530 covered companies
CURRENT VS SECTOR MEDIAN
+86997.97%
vs the sector median at left
Market Cap
$2.06B
Debt to Assets Ratio
0.03%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$2.04B
Debt to Assets Ratio
0.73%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$2.13B
Debt to Assets Ratio
0.07%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$2.13B
Debt to Assets Ratio
0.01%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$2.01B
Debt to Assets Ratio
0.08%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Alvotech (ALVO) | $2.07B | 91.45% | 94.69% | 99.88% | 96.73% |
| Inspire Medical Systems, Inc. (INSP)vs › | $2.06B | 0.03% | N/A | N/A | N/A |
| BioCryst Pharmaceuticals, Inc. (BCRX)vs › | $2.04B | 0.73% | N/A | N/A | N/A |
| Azenta, Inc. (AZTA)vs › | $2.11B | 0.03% | N/A | N/A | N/A |
| Addus HomeCare Corporation (ADUS)vs › | $2.13B | 0.07% | N/A | N/A | N/A |
| Celldex Therapeutics, Inc. (CLDX)vs › | $2.13B | 0.01% | N/A | N/A | N/A |
| Aurinia Pharmaceuticals Inc. (AUPH)vs › | $2.01B | 0.08% | N/A | N/A | N/A |
| Absci Corporation (ABSI)vs › | $2.00B | 0.01% | N/A | N/A | N/A |
| AxoGen, Inc. (AXGN)vs › | $1.99B | 0.07% | N/A | N/A | N/A |
| Immunome, Inc. (IMNM)vs › | $1.99B | 0.01% | N/A | N/A | N/A |
Debt/Assets
91.5%
Debt/Equity
N/A
Current Ratio
1.65
Interest Coverage
0.5x
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-06-30 | 91.45% |
| 2026-03-31 | 102.54% |
| 2025-12-31 | 97.45% |
| 2025-09-30 | 90.99% |
| 2025-06-30 | 91.04% |
| 2025-03-31 | 98.51% |
| 2024-12-31 | 97.45% |
| 2024-09-30 | 95.75% |
| 2024-06-30 | 111.23% |
| 2024-03-31 | 103.70% |
| 2023-12-31 | 113.20% |
| 2023-08-31 | 105.86% |
| 2023-06-30 | 99.27% |
| 2023-03-31 | 93.34% |
| 2022-12-31 | 97.18% |
| 2022-09-30 | 93.21% |
| 2022-06-30 | 88.01% |
| 2022-03-31 | 0.05% |
| 2021-12-31 | 87.47% |
| 2021-09-30 | 0.05% |
| 2021-06-30 | 0.05% |
| 2021-03-31 | 0.05% |
| 2020-12-31 | 142.67% |
| 2020-09-30 | 0.10% |
| 2020-06-30 | 119.70% |
| 2020-03-31 | 119.70% |
